CompoAtlas

Huile essentielle de Cannelle de Ceylan

Food supplement declared in France, declaration No 2022-5-138, decision dated 4 May 2022

Huile essentielle de Cannelle de Ceylan (PHIMEA) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Cinnamomum verum 98 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
PHIMEA
Food business operator placing the product on the market
PHIMEA
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Dropper
Daily dose
98mg
Directions for use
Prendre au maximum 1 goutte, 3 fois par jour
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Prolonged use, Children (under 6), Children (under 10)

Declaration 324979, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Cinnamomum verum J. PreslEssence (bois, écorce)Distillation98 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Ne pas utiliser pure, ni diluée dans de l'eau. Ne pas dépasser la dose journalière recommandée. Ce produit ne peut en aucun cas remplacer une alimentation équilibrée et variée ainsi qu'un mode de vie sain. Il est recommandé de suivre les conseils d'utilisation d'un professionnel de santé avant d'utiliser les huiles essentielles. Réservé à l'adulte. Ne pas utiliser sans avis médical chez les femmes enceintes ou allaitant, les personnes ayant des troubles gastro-oesophagiens ou de coagulation du sang, les personnes sous anticoagulants ou antidiabétiques oraux, les personnes allergiques à la cannelle ou au baume du Pérou. Nepas dépasser 1 semaine de prise. Tenir hors de portée des enfants. Conserver le flacon bien fermé dans un endroit frais et à l’abri de la lumière.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Cinnamomum verum J. Presl
    Read the warning, when it applies and the studies cited

    Cinnamon - Cinnamomum Verum

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Blumenthal et al. 2000; WHO 1999).

    Sources cited by Health Canada (4)
    • Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): American Botanical Council. 2000.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • WHO 1999: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1. Geneva (CH): World Health Organization; 1999.
    • OMS 1999: Organisation mondiale de la santé (OMS). Monographs on Selected Medicinal Plants : Volume 1. Geneva (CHE) : Organisation mondiale de la santé.

    Condition of application: All products except antioxidants.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant (Brinker 2010; BHC 2006; Blumenthal 2000).

    Sources cited by Health Canada (3)
    • Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): American Botanical Council. 2000.
    • BHC 2006: Bradley PR, editor. British Herbal Compendium Volume 2: A Handbook of Scientific Information on Widely Used Plant Drugs—Companion to the British Herbal Pharmacopoeia. Bournemouth (GB): British Herbal Medicine Association; 2006.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Health Canada monograph dated 26 July 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : PHIMEA

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Huile essentielle de Cannelle de Ceylan (PHIMEA): composition and regulation”, https://compoatlas.com/en/supplements/products/324979-huile-essentielle-de-cannelle-de-ceylan, updated 15 November 2026.

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line